BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6814466)

  • 1. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
    Muchnik S
    Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 5. [Card-Hydergin for treatment of heart insufficiency in elderly patients with cerebrovascular deficiency].
    Schmidt W
    ZFA (Stuttgart); 1977 Mar; 53(8):447-52. PubMed ID: 324165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropsychological deficits in right hemisphere stroke patients. I: Methods and results from factor analysis.
    Finset A
    J Oslo City Hosp; 1988; 38(8-9):77-83. PubMed ID: 3241286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
    Biel ML; Seus R; Struppler A
    Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of cerebrovascular insufficiency].
    Cosentino F; Baldassarri R
    Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trials in the treatment of cerebrovascular insufficiency with the monodrug dihydroergocristine. A multicentric study].
    Finke J; Haehn KD; Haase W
    Med Welt; 1982 Jul; 33(28):1042-7. PubMed ID: 6811832
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study and clinico-psychological evaluation of a preparation with neurotrophic effects].
    Montini M; Ongaro A; Simonutti M
    Clin Ter; 1977 Aug; 82(3):243-62. PubMed ID: 334449
    [No Abstract]   [Full Text] [Related]  

  • 13. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
    Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
    Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

  • 15. The objective measurement of mental performance in cerebrovascular disease. A double-blind controlled study, using a graded-release preparation of isoxsuprine.
    Hussain SM; Gedye JL; Naylor R; Brown AL
    Practitioner; 1976 Feb; 216(1292):222-8. PubMed ID: 772660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate use in neuropsychiatric disorders in the elderly.
    Tariot PN
    Psychopharmacol Bull; 2003; 37 Suppl 2():116-28. PubMed ID: 15021866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 18. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 19. Caution on the potential usefulness of statins in neuropsychiatric diseases.
    Brondino N; Emanuele E; Geroldi D
    Med Hypotheses; 2007; 69(3):697. PubMed ID: 17350766
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of cerebral wasting diseases with Card-Hydergin].
    Liebhart M
    Med Welt; 1976 Nov; 76(48):2341-6. PubMed ID: 794620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.